ANAGRELIDE

SynDRA canonical compound SYN0001729 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	PDE3A
Mechanism of action	Phosphodiesterase inhibitor
Indication	myeloproliferative neoplasms \| thrombocythemia
Disease area	hematologic malignancy \| hematology

All known targets

xagrid
anagrelide hydrochloride
anagrelide hydrochloride hydrate
anagrelide HCl
anagrelide hydrochloride monohydrate
Anagrelida
Anagrelidum
BL 416201
Agrylin (TN)
Anagrelida [INN-Spanish]
Anagrelide [BAN:INN]
Anagrelide [INN:BAN]
Anagrelidum [INN-Latin]
Xagrid (TN)
Anagrelide (INN/BAN)
6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on
6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one
6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one
6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one
Xagrid
6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
CHEMBL760
CHEBI:142290
Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-
K9X45X0051
BL-4162A
6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
6,7-dichloro-1H,2H,3H,5H-imidazolidino[2,1-b]quinazolin-2-one
6,7-bis(chloranyl)-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one
Imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-
HSDB 7325
BRN 0619582
6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one
UNII-K9X45X0051
Imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, monohydrochloride
ANAGRELIDE [MI]
ANAGRELIDE [INN]
ANAGRELIDE [HSDB]